BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22528665)

  • 1. Transcriptional and post-transcriptional regulation in TGF-β-mediated epithelial-mesenchymal transition.
    Saitoh M; Miyazawa K
    J Biochem; 2012 Jun; 151(6):563-71. PubMed ID: 22528665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.
    Saitoh M
    Cancer Sci; 2015 May; 106(5):481-8. PubMed ID: 25664423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
    Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
    J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.
    Thuault S; Valcourt U; Petersen M; Manfioletti G; Heldin CH; Moustakas A
    J Cell Biol; 2006 Jul; 174(2):175-83. PubMed ID: 16831886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
    Imamura T; Hikita A; Inoue Y
    Breast Cancer; 2012 Apr; 19(2):118-24. PubMed ID: 22139728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β.
    Valcourt U; Carthy J; Okita Y; Alcaraz L; Kato M; Thuault S; Bartholin L; Moustakas A
    Methods Mol Biol; 2016; 1344():147-81. PubMed ID: 26520123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
    Lee HS; Kim C; Kim SB; Kim MG; Park D
    Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition.
    Wu CY; Tsai YP; Wu MZ; Teng SC; Wu KJ
    Trends Genet; 2012 Sep; 28(9):454-63. PubMed ID: 22717049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of epithelial-mesenchymal transition by transforming growth factor β.
    Moustakas A; Heldin CH
    Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer.
    Wu YY; Peck K; Chang YL; Pan SH; Cheng YF; Lin JC; Yang RB; Hong TM; Yang PC
    Oncogene; 2011 Aug; 30(34):3682-93. PubMed ID: 21441952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of EMT by TGFβ in cancer.
    Heldin CH; Vanlandewijck M; Moustakas A
    FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
    Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
    Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
    Mercado-Pimentel ME; Runyan RB
    Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands.
    Del Castillo G; Murillo MM; Alvarez-Barrientos A; Bertran E; Fernández M; Sánchez A; Fabregat I
    Exp Cell Res; 2006 Sep; 312(15):2860-71. PubMed ID: 16828470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Lnc-Spry1 mediates TGF-β-induced epithelial-mesenchymal transition by transcriptional and posttranscriptional regulatory mechanisms.
    Rodríguez-Mateo C; Torres B; Gutiérrez G; Pintor-Toro JA
    Cell Death Differ; 2017 May; 24(5):785-797. PubMed ID: 28186499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Encounter of cancer cells with bone. Epithelial-mesenchymal transition in cancer].
    Horiguchi K; Saitoh M
    Clin Calcium; 2011 Mar; 21(3):405-10. PubMed ID: 21358062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.